Erectile Dysfunction Risk: Farxiga vs Hydrochlorothiazide
Hydrochlorothiazide (a thiazide diuretic) is associated with causing erectile dysfunction, while Farxiga (dapagliflozin) actually improves erectile function in men with diabetes.
Hydrochlorothiazide and Erectile Dysfunction
Thiazide diuretics like hydrochlorothiazide have the highest association with erectile dysfunction among antihypertensive medications. 1, 2
Evidence of Causation
In the Treatment of Mild Hypertension Study (TOMHS), men randomized to chlorthalidone (a thiazide diuretic) reported a significantly higher incidence of erection problems through 24 months compared to placebo (17.1% versus 8.1%, P = .025). 3
The American College of Cardiology identifies thiazide diuretics as having the highest association with erectile dysfunction among antihypertensive agents. 1
Beta-blockers, thiazide diuretics, and mineralocorticoid receptor antagonists have the strongest links to erectile dysfunction compared to other antihypertensive drug classes. 1, 2
Clinical Management Approach
If erectile dysfunction appears after starting hydrochlorothiazide, consider switching to an alternative antihypertensive agent before adding ED-specific treatment. 1
Preferred alternatives include ACE inhibitors, ARBs, and calcium channel blockers, which have not been observed to increase erectile dysfunction incidence. 1
If hydrochlorothiazide must be continued for specific clinical indications, treat the erectile dysfunction with phosphodiesterase-5 inhibitors (sildenafil, tadalafil, vardenafil), which can be safely coadministered with antihypertensive medications. 1, 4
Farxiga (Dapagliflozin) and Erectile Function
Dapagliflozin improves erectile dysfunction in men with type 2 diabetes rather than causing it. 5
Evidence of Benefit
In a 2024 pilot study, men with type 2 diabetes and severe erectile dysfunction treated with dapagliflozin 10 mg/day for 3 months showed a 197% improvement in IIEF-5 scores. 5
When dapagliflozin was combined with tadalafil 5 mg/day, the improvement was even greater (375% increase in IIEF-5 scores), demonstrating that dapagliflozin enhances the efficacy of PDE5 inhibitors. 5
Penile color Doppler ultrasound showed significant increases in peak systolic velocity (153% with dapagliflozin alone, 339% when combined with tadalafil), indicating improved penile blood flow. 5
Important Clinical Caveats
Don't Overlook the Underlying Disease
Hypertension itself causes endothelial dysfunction and vascular changes that contribute to erectile dysfunction independent of medication effects. 1, 2, 6
Diabetes mellitus is associated with erectile dysfunction prevalence as high as 75%, occurring at an earlier age than in non-diabetic men. 6, 7
Men with diabetes have a twofold increased incidence rate of erectile dysfunction (50 cases/1000 man-years) compared to non-diabetic men. 7
Screen Proactively
Erectile dysfunction affects up to 40% of hypertensive men and is often under-reported due to patient embarrassment and physician discomfort discussing the topic. 1
New onset or progressive erectile dysfunction should be considered an alarming marker of threatening ischemic heart disease, even at asymptomatic stages. 7
Erectile dysfunction shares common risk factors with cardiovascular disease and warrants comprehensive cardiovascular risk assessment. 1, 7
Treatment Priorities
PDE5 inhibitors (sildenafil, tadalafil, vardenafil) are first-line therapy for erectile dysfunction in patients with controlled hypertension and can be safely coadministered with antihypertensive medications. 1, 7
The absolute contraindication is concurrent nitrate use in any form (sublingual, oral, transdermal, or recreational "poppers"), which can cause severe, potentially fatal hypotension. 1, 4
Address modifiable risk factors including physical activity, weight loss, smoking cessation, diabetes control, and lipid management, as these reduce erectile dysfunction risk independent of blood pressure control. 1